These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29385907)

  • 1. Analysis of synovial fluid visfatin level in temporomandibular joint disorders.
    Yapıcı Yavuz G; Şimşek Kaya G; Kızıltunç A
    Cranio; 2019 Sep; 37(5):296-303. PubMed ID: 29385907
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of chemerin in the synovial fluid of patients with temporomandibular joint disorders.
    Şimşek Kaya G; Yapıcı Yavuz G; Kızıltunç A
    J Oral Rehabil; 2018 Apr; 45(4):289-294. PubMed ID: 29331039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease.
    Kubota E; Kubota T; Matsumoto J; Shibata T; Murakami KI
    J Oral Maxillofac Surg; 1998 Feb; 56(2):192-8. PubMed ID: 9461144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis.
    Chen WP; Bao JP; Feng J; Hu PF; Shi ZL; Wu LD
    Clin Chem Lab Med; 2010 Aug; 48(8):1141-5. PubMed ID: 20482384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis.
    Duan Y; Hao D; Li M; Wu Z; Li D; Yang X; Qiu G
    Rheumatol Int; 2012 Apr; 32(4):985-90. PubMed ID: 21246369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint.
    Kubota E; Imamura H; Kubota T; Shibata T; Murakami K
    J Oral Maxillofac Surg; 1997 Jan; 55(1):20-7; discussion 27-8. PubMed ID: 8994464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporomandibular joint pain: relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-alpha.
    Emshoff R; Puffer P; Rudisch A; Gassner R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):442-9. PubMed ID: 11027380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis.
    Laiguillon MC; Houard X; Bougault C; Gosset M; Nourissat G; Sautet A; Jacques C; Berenbaum F; Sellam J
    Arthritis Res Ther; 2014 Jan; 16(1):R38. PubMed ID: 24479481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteoglycans in the synovial fluid of the temporomandibular joint as an indicator of changes in cartilage metabolism during primary and secondary osteoarthritis.
    Ratcliffe A; Israel HA; Saed-Nejad F; Diamond B
    J Oral Maxillofac Surg; 1998 Feb; 56(2):204-8. PubMed ID: 9461146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-beta1 in synovial fluid aspirates of patients with temporomandibular disorders.
    Fang PK; Ma XC; Ma DL; Fu KY
    J Oral Maxillofac Surg; 1999 Aug; 57(8):922-8; discussion 928-9. PubMed ID: 10437719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between arthroscopic diagnosis of temporomandibular joint osteoarthritis and synovial fluid nitric oxide levels.
    Takahashi T; Kondoh T; Ohtani M; Homma H; Fukuda M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Aug; 88(2):129-36. PubMed ID: 10468453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of aggrecan and adipokine levels in temporomandibular joint synovial fluid.
    Bayındır Ş; Yılmaz Asan C; Demirbaş AE; Keti DB; Kütük N
    J Craniomaxillofac Surg; 2022 May; 50(5):432-438. PubMed ID: 35491326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophoretic separation of the synovial fluid proteins in patients with temporomandibular joint disorders.
    Fujimura K; Segami N; Yoshitake Y; Tsuruoka N; Kaneyama K; Sato J; Kobayashi S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):463-8. PubMed ID: 16545710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HMGB1 levels in synovial fluid with the severity of temporomandibular joint osteoarthritis.
    Shao B; Xu Y; Jia M; Li CX; Gong ZC
    BMC Musculoskelet Disord; 2023 Mar; 24(1):183. PubMed ID: 36906519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of osteoclast-like cells derived from the synovial lavage fluids of patients with temporomandibular joint disorders.
    Takano H; Ariyoshi W; Kanno T; Fukuhara E; Ichimiya H; Matayoshi T; Goto T; Takahashi T
    Osteoarthritis Cartilage; 2007 Mar; 15(3):291-9. PubMed ID: 16979913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine and substance P in synovial fluid of patients with temporomandibular disorders.
    Li W; Long X; Jiang S; Li Y; Fang W
    J Oral Rehabil; 2015 May; 42(5):363-9. PubMed ID: 25545415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Dickkopf-related Protein 1 in Patients with Temporomandibular Osteoarthritis after Treatment with Hyaluronic Acid.
    Jiang SJ; Jin ZZ; Peng YJ
    Curr Med Sci; 2020 Jun; 40(3):574-579. PubMed ID: 32681262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between joint effusion, joint pain, and protein levels in joint lavage fluid of patients with internal derangement and osteoarthritis of the temporomandibular joint.
    Takahashi T; Nagai H; Seki H; Fukuda M
    J Oral Maxillofac Surg; 1999 Oct; 57(10):1187-93; discussion 1193-4. PubMed ID: 10513864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders.
    Kaneyama K; Segami N; Sato J; Nishimura M; Yoshimura H
    Br J Oral Maxillofac Surg; 2004 Jun; 42(3):246-50. PubMed ID: 15121272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of temporomandibular joint arthrocentesis on synovial fluid mediator level of tumor necrosis factor-alpha: implications for treatment outcome.
    Emshoff R; Puffer P; Strobl H; Gassner R
    Int J Oral Maxillofac Surg; 2000 Jun; 29(3):176-82. PubMed ID: 10970078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.